scholarly journals Rapid Identification of Escherichia coli Colistin-Resistant Strains by MALDI-TOF Mass Spectrometry

2021 ◽  
Vol 9 (11) ◽  
pp. 2210
Author(s):  
Adriana Calderaro ◽  
Mirko Buttrini ◽  
Benedetta Farina ◽  
Sara Montecchini ◽  
Monica Martinelli ◽  
...  

Colistin resistance is one of the major threats for global public health, requiring reliable and rapid susceptibility testing methods. The aim of this study was the evaluation of a MALDI-TOF mass spectrometry (MS) peak-based assay to distinguish colistin resistant (colR) from susceptible (colS) Escherichia coli strains. To this end, a classifying algorithm model (CAM) was developed, testing three different algorithms: Genetic Algorithm (GA), Supervised Neural Network (SNN) and Quick Classifier (QC). Among them, the SNN- and GA-based CAMs showed the best performances: recognition capability (RC) of 100% each one, and cross validation (CV) of 97.62% and 100%, respectively. Even if both algorithms shared similar RC and CV values, the SNN-based CAM was the best performing one, correctly identifying 67/71 (94.4%) of the E. coli strains collected: in point of fact, it correctly identified the greatest number of colS strains (42/43; 97.7%), despite its lower ability in identifying the colR strains (15/18; 83.3%). In conclusion, although broth microdilution remains the gold standard method for testing colistin susceptibility, the CAM represents a useful tool to rapidly screen colR and colS strains in clinical practice.

2019 ◽  
Author(s):  
R. Christopher D. Furniss ◽  
Laurent Dortet ◽  
William Bolland ◽  
Oliver Drews ◽  
Katrin Sparbier ◽  
...  

ABSTRACTPolymyxin antibiotics are a last-line treatment for multidrug-resistant Gram-negative bacteria. However, the emergence of colistin resistance, including the spread of mobile mcr genes, necessitates the development of improved diagnostics for the detection of colistin-resistant organisms in hospital settings. The recently developed MALDIxin test enables detection of colistin resistance by MALDI-TOF mass spectrometry in less than 15 minutes but is not optimized for the mass spectrometers commonly found in clinical microbiology laboratories. In this study, we adapted the MALDIxin test for the MALDI Biotyper Sirius MALDI-TOF mass spectrometry system (Bruker Daltonics). We optimized the sample preparation protocol using a set of 6 MCR-expressing Escherichia coli clones and validated the assay with a collection of 40 E. coli clinical isolates, including 19 MCR producers, 12 chromosomally-resistant isolates and 9 polymyxin-susceptible isolates. We calculated Polymyxin resistance ratio (PRR) values from the acquired spectra; a PRR value of zero, indicating polymyxin susceptibility, was obtained for all colistin-susceptible E. coli isolates, whereas positive PRR values, indicating resistance to polymyxins, were obtained for all resistant strains independent of the genetic basis of resistance. Thus, we report a preliminary feasibility study showing that an optimized version of the MALDIxin test, adapted for the routine MALDI Biotyper Sirius, provides an unbiased, fast, reliable, cost-effective and high-throughput way of detecting colistin resistance in clinical E. coli isolates.


2014 ◽  
Vol 226 (02) ◽  
pp. 68-71 ◽  
Author(s):  
M. Artacho-Reinoso ◽  
P. Olbrich ◽  
P. Solano-Paéz ◽  
P. Ybot-Gonzalez ◽  
J. Lepe ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0185935 ◽  
Author(s):  
Elena De Carolis ◽  
Silvia Paoletti ◽  
Domenico Nagel ◽  
Antonietta Vella ◽  
Enrica Mello ◽  
...  

2016 ◽  
Vol 8 (1) ◽  
Author(s):  
Luigi Principe ◽  
Silvia Bracco ◽  
Carola Mauri ◽  
Silvia Tonolo ◽  
Beatrice Pini ◽  
...  

<em>Erysipelothrix</em> <em>rhusiopathiae</em> is a Gram-positive bacillus that is infrequently responsible for infections in humans. Three forms have been classified: a localized cutaneous form (erysipeloid) caused by traumatic penetration of <em>E.</em> <em>rhusiopathiae</em>, a generalized cutaneous form and a septicemic form. The latter type of disease has been previously associated with a high incidence of endocarditis. Here we report a case of <em>E. rhusiopathiae</em> bacteremia in a 74- year-old man, probably started from an erysipeloid form, in which endocarditis did not develop. This case presents some particular and uncommon features: i) no correlation with animal source; ii) correlation between bacteremia and erysipeloid lesion; iii) absence of endocarditis. MALDI-TOF mass spectrometry allowed to obtain a rapid identification (within 4 hours from bottle positivity) of <em>E. rhusiopathiae</em>. Together with direct antimicrobial susceptibility testing, this approach could improve the rate of appropriate therapy for bloodstream infections due to this fastidious pathogen.


2018 ◽  
Vol 19 (2) ◽  
pp. 394-407 ◽  
Author(s):  
Nikola HRICÁKOVÁ ◽  
Juraj MEDO ◽  
Lukáš HLEBA ◽  
Marek BARTA ◽  
Jana MAKOVÁ

2015 ◽  
Vol 109 ◽  
pp. 93-105 ◽  
Author(s):  
Ashutosh Panda ◽  
Anup K. Ghosh ◽  
Bijay R. Mirdha ◽  
Immaculata Xess ◽  
Saikat Paul ◽  
...  

2010 ◽  
Vol 33 (9) ◽  
pp. 568-574 ◽  
Author(s):  
Llinos G. Harris ◽  
Khalid El-Bouri ◽  
Stuart Johnston ◽  
Eugene Rees ◽  
Lars Frommelt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document